A Prospective Investigation of the Association between Urinary Excretion of Dietary Lignan Metabolites and Weight Change in US Women

American Journal of Epidemiology

Volumn 182, Issue 6, 2015, Pages 503-511

  Hu, Yang ^a   Song, Yan ^b   Franke, Adrian A ^c   Hu, Frank B ^a,d   Van Dam, Rob M ^e   Sun, Qi ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF HAWAII AT MANOA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Enterodiol; enterolactone; lignan; weight change

Indexed keywords

ALCOHOL; ENDOCRINE DISRUPTOR; ENTERODIOL; ENTEROLACTONE; LIGNAN; 2,3-BIS(3'-HYDROXYBENZYL)BUTANE-1,4-DIOL; 2,3-BIS(3'-HYDROXYBENZYL)BUTYROLACTONE; GAMMA BUTYROLACTONE;

BODY MASS; CHEMICAL COMPOUND; DIET; EXCRETION; HEALTH MONITORING; METABOLITE; MICROBIAL ACTIVITY; MULTIVARIATE ANALYSIS; PHENOLIC COMPOUND; URINE; WEIGHT; WOMENS HEALTH;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GRAIN; HUMAN; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROSPECTIVE STUDY; RED WINE; SMOKING; URINALYSIS; URINARY EXCRETION; VEGETABLE; WEIGHT CHANGE; WEIGHT GAIN; ANALOGS AND DERIVATIVES; BODY WEIGHT; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DIET THERAPY; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; UNITED STATES; URINE;

UNITED STATES;

ANIMALIA;

4-BUTYROLACTONE; ADULT; AGED; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIGNANS; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES; URINALYSIS;

EID: 84941621315     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv091     Document Type: Article

References (38)

1. Stettler N, Kumanyika SK, Katz SH, et al. Rapid weight gain during infancy and obesity in young adulthood in a cohort of African Americans. Am J Clin Nutr. 2003;77(6): 1374-1378.
2. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997; 278(17):1407-1411.
3. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17(9):961-969.
4. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA. 1995;273(6):461-465.
5. Ogden C, Carroll M, Kit B, et al. Prevalence of Obesity in the United States, 2009-2010. Hyattsville, MD: National Center for Health Statistics; 2012.
6. Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392-2404.
7. Peterson J, Dwyer J, Adlercreutz H, et al. Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev. 2010;68(10):571-603.
8. Landete JM. Plant and mammalian lignans: a review of source, intake, metabolism, intestinal bacteria and health. Food Res Int. 2012;46(1):410-424.
9. Chen JQ, Brown TR, Russo J. Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta. 2009;1793(7): 1128-1143.
10. Fukumitsu S, Aida K, Ueno N, et al. Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr. 2008;100(3):669-676.
11. Park JB, Velasquez MT. Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid profile, and blood pressure in rats. Fitoterapia. 2012;83(5):941-946.
12. Kilkkinen A, Stumpf K, Pietinen P, et al. Determinants of serum enterolactone concentration. Am J Clin Nutr. 2001;73(6): 1094-1100.
13. Morisset A-S, Lemieux S, Veilleux A, et al. Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women. Br J Nutr. 2009;102(2):195-200.
14. De Kleijn MJ, van der Schouw YT, Wilson PW, et al. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham Study. J Nutr. 2002;132(2): 276-282.
15. Song Y, Hauser R, Hu FB, et al. Urinary concentrations of bisphenol A and phthalate metabolites and weight change: a prospective investigation in US women. Int J Obes (Lond). 2014;38(12):1532-1537.
16. Willett W, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117(6): 651-658.
17. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18(4):858-867.
18. Chiuve SE, Fung TT, Rimm EB, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142(6):1009-1018.
19. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 1999;149(6):531-540.
20. Franke AA, Custer LJ, Wilkens LR, et al. Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 777(1-2):45-59.
21. Milder IE, Feskens EJ, Arts IC, et al. Intake of the plant lignans secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol in Dutch men and women. J Nutr. 2005;135(5):1202-1207.
22. Low Y-L, Taylor JI, Grace PB, et al. Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions. Cancer Epidemiol Biomarkers Prev. 2005;14(1):213-220.
23. Touillaud MS, Pillow PC, Jakovljevic J, et al. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer. 2005; 51(2):162-169.
24. Hart-Unger S, Korach KS. Estrogens and obesity: is it all in our heads? Cell Metab. 2011;14(4):435-436.
25. Yan L, Ge H, Li H, et al. Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J Mol Cell Cardiol. 2004;37(5):921-929.
26. Pastorelli R, Carpi D, Airoldi L, et al. Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone. Proteomics. 2005;5(18):4936-4945.
27. Reiss NA. Ontogeny and estrogen responsiveness of creatine kinase and glycolytic enzymes in brain and uterus of rat. Neurosci Lett. 1988;84(2):197-202.
28. Kostanyan A, Nazaryan K. Rat brain glycolysis regulation by estradiol-17 beta. Biochim Biophys Acta. 1992;1133(3): 301-306.
29. Bogacka I, Roane DS, Xi X, et al. Expression levels of genes likely involved in glucose-sensing in the obese Zucker rat brain. Nutr Neurosci. 2004;7(2):67-74.
30. Houston KD, Copland JA, Broaddus RR, et al. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. Cancer Res. 2003;63(6):1221-1227.
31. Penttinen P, Jaehrling J, Damdimopoulos AE, et al. Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology. 2007;148(10):4875-4886.
32. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf ). 2006;186(1):5-16.
33. Soriano S, Alonso-Magdalena P, Garciá-Arévalo M, et al. Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor ?. PLoS One. 2012;7(2):e31109.
34. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA. 2007;104(32):13056-13061.
35. Wang X, Kilgore MW. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol. 2002; 194(1-2):123-133.
36. Hurst CH, Waxman DJ. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci. 2003;74(2):297-308.
37. Feige JN, Gelman L, Rossi D, et al. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem. 2007;282(26):19152-19166.
38. Desvergne B, Feige JN, Casals-Casas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol. 2009;304(1-2):43-48.